| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Pace Gary W is a Director at Cardiff Oncology, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 11 buys and 6 sells.
Estimated insider holdings value: $23.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30, 2025 | CRDF Cardiff Oncology, Inc. | Director | Buy | 290,000 | $2.45 | $710,500.00 | +12.2% | -7.6% | - | |
| Dec 11, 2024 | CRDF Cardiff Oncology, Inc. | Director | Buy | 361,615 | $2.60 | $940,199.00 | +20.7% | -3.2% | -33.1% | |
| Mar 8, 2024 | PCRX Pacira Biosciences, Inc. | Director | Sell | 119,323 | $30.64 | $3,656,226.39 | -30.3% | -7.3% | -25.6% | |
| Dec 19, 2023 | CRDF Cardiff Oncology, Inc. | Director | Buy | 30,000 | $1.37 | $41,100.00 | +4.5% | +280.1% | +230.1% | |
| Nov 10, 2023 | CRDF Cardiff Oncology, Inc. | Director | Buy | 22,950 | $0.98 | $22,491.00 | +3.6% | +80.0% | +208.0% | |
| May 11, 2023 | PCRX Pacira Biosciences, Inc. | Director | Sale+OE | 5,015 | $41.78 | $209,526.70 | -3.5% | -9.4% | -30.0% | |
| Sep 15, 2022 | CRDF Cardiff Oncology, Inc. | Director | Buy | 150,000 | $1.71 | $256,500.00 | +30.3% | -15.6% | +3.6% | |
| Mar 1, 2022 | PCRX Pacira Biosciences, Inc. | Director | Sale+OE | 30,000 | $66.87 | $2,006,150.28 | -10.4% | -6.5% | -35.9% | |
| Sep 21, 2021 | CRDF Cardiff Oncology, Inc. | Director | Buy | 30,000 | $6.75 | $202,500.00 | +6.5% | -8.8% | -74.3% | |
| Mar 23, 2021 | CRDF Cardiff Oncology, Inc. | Director | Buy | 10,000 | $10.23 | $102,300.00 | +0.7% | -22.3% | -75.7% |